Prim, S.A. (BME:PRM)

Market Cap	231.42M +38.5%
Revenue (ttm)	240.68M +5.8%
Net Income	14.55M +27.4%
EPS	0.85 +27.1%
Shares Out	17.02M
PE Ratio	16.00
Forward PE	14.10
Dividend	0.47 (3.61%)
Ex-Dividend Date	Mar 10, 2026

Volume	12,991
Average Volume	3,784
Open	12.95
Previous Close	13.00
Day's Range	12.95 - 13.80
52-Week Range	9.06 - 13.95
Beta	0.49
RSI	63.70
Earnings Date	Feb 27, 2026

About Prim, S.A.

Prim, S.A. operates as a health technology, mobility, and health care products provider in Spain. The company offers collar, clavicle, armsling, hand and finger, shoulder, elbow, and wrist products. Its lower limbs products include calf brace, thigh, hip, knee, ankle, and foot related products. The company provides shoulder and back supports, bands, corsets, hyperextension braces, and thoracic protectors under the airtex PRO, bruxi calm, fisionprim, newfeet, ORTHOPrim, PRIM, PRIMcare, respira PLUS, airMed, airtex, aqtivo skin, aqtivo sport, com...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1870
• Employees: 902
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: PRM

Financial Performance

In 2024, Prim, S.A.'s revenue was 233.36 million, an increase of 7.73% compared to the previous year's 216.62 million. Earnings were 10.92 million, a decrease of -13.83%.